Watch for Q3 2026 earnings call in November for initial 2027 combined guidance and integration details. Key catalysts: closing of the deal (expected Q4 2026), US patient ramp, and 2027 earnout targets. The 3.85M shares issued represent ~3-4% dilution based on Grindr's ~100M share count, manageable for a transformative acquisition.
Price Chart
Executive Summary
Grindr has agreed to acquire PurposeMed Inc. (Freddie), a leading telehealth provider of PrEP and HIV prevention care, for $250 million in upfront consideration ($190M cash + $60M stock) plus up to $70M in earnout based on 2027 performance. The deal accelerates Grindr Health, integrating Freddie's clinical and pharmacy operations into the Grindr app to reach millions of users. Freddie expects 2026 revenue >$80M and >$10M Adjusted EBITDA, with long-term healthcare margins targeted at 40%+. The transaction is expected to close in Q4 2026.
Key Facts
- Base purchase price of $250 million: $190 million cash + $60 million in Grindr common stock (3,851,684 shares at $15.58/share).
- Up to $70 million in additional cash earnout tied to 2027 performance targets, payable in 2028.
- Freddie expects 2026 revenue >$80 million and >$10 million Adjusted EBITDA.
- Long-term healthcare margin target of 40%+, in line with core Grindr margins.
- Freddie has served over 55,000 patients across Canada and all 50 US states.
- Transaction expected to close in Q4 2026, subject to regulatory approvals and closing conditions.
- Grindr shares issued in the deal are subject to a 12-month lock-up.
- Freddie's leadership team will join Grindr to build Grindr Health.
Financial Impact
$250 million upfront ($190M cash + $60M stock) plus up to $70M earnout; Freddie 2026E revenue >$80M, Adj. EBITDA >$10M
Risk Factors
- Integration risk: merging Freddie's clinical/pharmacy operations with Grindr's platform.
- Regulatory risk: pharmacy change-of-control filings and other healthcare regulatory approvals may delay or prevent closing.
- Execution risk: achieving 2027 earnout targets and scaling US patient base to 50,000+.
- Dilution: 3.85M shares issued at $15.58/share, subject to 12-month lock-up.
- Healthcare margin target of 40%+ may take longer to achieve if US ramp is slower than expected.
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001820144-26-000033 |
| Exhibit: exhibit992-shareholderle.htm | 0001820144-26-000033 |
| Exhibit: exhibit991-pressreleasedat.htm | 0001820144-26-000033 |
| Document: grnd-20260930.htm | 0001820144-26-000033 |
| Document: 0001820144-26-000033-index-headers.html | 0001820144-26-000033 |
| Document: 0001820144-26-000033-index.html | 0001820144-26-000033 |
| Document: 0001820144-26-000033.txt | 0001820144-26-000033 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 6d ago | Insider Cluster | $13.73 | awaiting T+5 | — | $13.12 (+4.44%) |
Sep 30, 2026 26d ago | 8-K | $14.17 $14.94 | ▲ +5.43% | ▲ +4.13% | $13.12 (−7.41%) |
Sep 18, 2026 5w ago | Insider Cluster | $15.89 $15.61 | ▲ +1.76% | ▲ +0.74% | $13.12 (+17.43%) |
Aug 21, 2026 9w ago | Insider Cluster | $15.58 $15.48 | ▼ −0.64% | ▼ −1.11% | $13.12 (−15.79%) |
Jul 1, 2026 16w ago | 144 | $16.06 $16.00 | ▼ −0.37% | ▼ −1.30% | $13.12 (−18.31%) |
Jun 17, 2026 18w ago | 3 | $13.35 $13.56 | ▲ +1.57% | ▲ +3.24% | $13.12 (−1.72%) |
Jun 11, 2026 19w ago | Institutional Cluster | $11.47 $13.28 | ▲ +15.78% | ▲ +15.35% | $13.12 (+14.39%) |
Jun 5, 2026 20w ago | 8-K | $11.04 $12.63 | ▲ +14.40% | ▲ +12.29% | $13.12 (+18.84%) |
Jun 4, 2026 20w ago | 3 | $10.90 $11.64 | ▲ +6.79% | ▲ +6.22% | $13.12 (+20.37%) |
Apr 30, 2026 25w ago | DEFA14A | $13.78 $15.09 | ▲ +9.51% | ▲ +7.16% | $13.12 (−4.79%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers